Haystack Oncology enables precision oncology to optimize treatment strategies.
Haystack Oncology has raised $56.0M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Haystack Oncology's investors include Catalio Capital Management, Alexandria Venture Investments, Bruker, Exact Ventures.
Haystack Oncology is headquartered in Baltimore, United States.
Haystack Oncology enables precision oncology to optimize treatment strategies.
Haystack Oncology is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Haystack Oncology — Funding & Investors." VCBacked, November 16, 2022, https://www.vcbacked.co/company/haystack-oncology. Accessed August 14, 2026.
VCBacked. (2022). Haystack Oncology — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/haystack-oncology
{{cite web |title=Haystack Oncology — Funding & Investors |url=https://www.vcbacked.co/company/haystack-oncology |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated